Glimex MV 2mg/500mg/0.2mg Tablet SR
Marketer
Zivago Pharma Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimex MV 2mg/500mg/0.2mg Tablet SR
Diabex Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabex Trio should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to hyperglycemia, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Glimex MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimex MV 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Glimex MV 2mg/500mg/0.2mg Extended-Release Tablets should be administered on an empty stomach.
Common Side effects of Glimex MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimex MV 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet whole; avoid chewing, crushing, or breaking it. Glimex MV 2mg/500mg/0.2mg Sustained-Release Tablets should be administered on an empty stomach.
How Glimex MV 2mg/500mg/0.2mg Tablet SR works:
Glimepiride, metformin, and pioglitazone, in a sustained-release tablet formulation (Glimex MV 2mg/500mg/0.2mg), provide triple-action diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Glimex MV 2mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimex MV 2mg/500mg/0.2mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimex MV 2mg/500mg/0.2mg tablet likely poses a risk during lactation. Available human data indicate potential transfer to breast milk, possibly endangering the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Glimex MV 2mg/500mg/0.2mg sustained-release tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, its administration is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimex MV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in severe cases.
What if you forget to take Glimex MV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glimex MV 2mg/500mg/0.2mg SR tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Glimex MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently